Abstract:
The introduction of Bioresorbable Vascular Scaffolds (BVS) has revolutionized the treatment of atherosclerosis. InSilc is an in silico clinical trial (ISCT) platform in a...Show MoreMetadata
Abstract:
The introduction of Bioresorbable Vascular Scaffolds (BVS) has revolutionized the treatment of atherosclerosis. InSilc is an in silico clinical trial (ISCT) platform in a Cloud-based environment used for the design, development and evaluation of BVS. Advanced multi-disciplinary and multiscale models are integrated in the platform towards predicting the short/acute and medium/long term scaffold performance. In this study, InSilc platform is employed in a use case scenario and demonstrates how the whole in silico pipeline allows the interpretation of the effect of the arterial anatomy configuration on stent implantation.
Published in: 2021 43rd Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC)
Date of Conference: 01-05 November 2021
Date Added to IEEE Xplore: 09 December 2021
ISBN Information:
ISSN Information:
PubMed ID: 34892153